Aortocoronary bypass grafting with expanded polytetrafluoroethylene: 12-year patency.
Prosthetic coronary artery bypass conduits are rarely used because the rate of thrombosis is inherently higher than that with autologous conduits. The low medium-term patency rates of prosthetic grafts have restricted their use primarily to patients with inadequate autologous conduits or to selected emergencies. We describe a patient treated with expanded polytetrafluoroethylene who had documented patency 12 years after the operation.
McLarty
A J
AJ
Section of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA.
Phillips
M R
MR
Holmes
D R
DR
Schaff
H V
HV
D000714:Anastomosis, Surgical; D015906:Angioplasty, Balloon, Coronary; D001807:Blood Vessel Prosthesis / Q000009:adverse effects; D019917:Blood Vessel Prosthesis Implantation; D001026:Coronary Artery Bypass / Q000379:methods; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000209:etiology / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011138:Polytetrafluoroethylene; D015607:Stents; D013927:Thrombosis / Q000209:etiology; D014182:Transplantation, Autologous; D014654:Vascular Patency
D011138:Polytetrafluoroethylene